UPDATE 2-Bristol, Pfizer anti-clot pill wins EU approval

surgery. In that study, it was compared with 30 milligrams of enoxaparin, dosed twice a day. Bristol-Myers and Pfizer, following the failed U.S. trial, have not asked U.S. regulators to approve Eliquis for orthopedic patients, or signaled an intention to...